• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用机器学习改进药物发现中的集成对接。

Using machine learning to improve ensemble docking for drug discovery.

机构信息

Department of Chemistry and Biochemistry and Center for Nanoscience, University of Missouri-St. Louis, Saint Louis, Missouri, USA.

出版信息

Proteins. 2020 Oct;88(10):1263-1270. doi: 10.1002/prot.25899. Epub 2020 May 25.

DOI:10.1002/prot.25899
PMID:32401384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7815257/
Abstract

Ensemble docking has provided an inexpensive method to account for receptor flexibility in molecular docking for virtual screening. Unfortunately, as there is no rigorous theory to connect the docking scores from multiple structures to measured activity, researchers have not yet come up with effective ways to use these scores to classify compounds into actives and inactives. This shortcoming has led to the decrease, rather than an increase in the performance of classifying compounds when more structures are added to the ensemble. Previously, we suggested machine learning, implemented in the form of a naïve Bayesian model could alleviate this problem. However, the naïve Bayesian model assumed that the probabilities of observing the docking scores to different structures to be independent. This approximation might prevent it from achieving even higher performance. In the work presented in this paper, we have relaxed this approximation when using several other machine learning methods-k nearest neighbor, logistic regression, support vector machine, and random forest-to improve ensemble docking. We found significant improvement.

摘要

基于分子对接的虚拟筛选中,对接配体时考虑受体柔性,集合 docking 提供了一种廉价的方法。遗憾的是,由于缺乏将来自多个结构的 docking 评分与测量活性相关联的严格理论,研究人员还没有找到有效方法来利用这些评分将化合物分类为活性和非活性。当向集合中添加更多结构时,这一缺陷导致化合物分类的性能下降,而不是提高。此前,我们提出了机器学习(以朴素贝叶斯模型的形式实现)可以缓解这一问题。然而,朴素贝叶斯模型假设观察不同结构的 docking 评分的概率是相互独立的。这种近似可能会阻止它实现更高的性能。在本文提出的工作中,我们放宽了使用其他几种机器学习方法(k 最近邻、逻辑回归、支持向量机和随机森林)来改进集合对接时的这一近似。我们发现了显著的改进。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/d62f78782ea7/nihms-1661970-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/65974396710b/nihms-1661970-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/a2e9959529a5/nihms-1661970-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/f137c0b9427b/nihms-1661970-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/9936f7b0651d/nihms-1661970-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/077d061a3521/nihms-1661970-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/8e540d01ee22/nihms-1661970-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/d62f78782ea7/nihms-1661970-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/65974396710b/nihms-1661970-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/a2e9959529a5/nihms-1661970-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/f137c0b9427b/nihms-1661970-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/9936f7b0651d/nihms-1661970-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/077d061a3521/nihms-1661970-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/8e540d01ee22/nihms-1661970-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5434/7815257/d62f78782ea7/nihms-1661970-f0007.jpg

相似文献

1
Using machine learning to improve ensemble docking for drug discovery.利用机器学习改进药物发现中的集成对接。
Proteins. 2020 Oct;88(10):1263-1270. doi: 10.1002/prot.25899. Epub 2020 May 25.
2
Assessing an ensemble docking-based virtual screening strategy for kinase targets by considering protein flexibility.评估基于对接的虚拟筛选策略对激酶靶点的影响,考虑蛋白质柔性。
J Chem Inf Model. 2014 Oct 27;54(10):2664-79. doi: 10.1021/ci500414b. Epub 2014 Sep 29.
3
Machine Learning Classification Models to Improve the Docking-based Screening: A Case of PI3K-Tankyrase Inhibitors.基于对接的筛选的机器学习分类模型:以 PI3K-Tankyrase 抑制剂为例。
Mol Inform. 2018 Nov;37(11):e1800030. doi: 10.1002/minf.201800030. Epub 2018 Jun 14.
4
Binding Activity Prediction of Cyclin-Dependent Inhibitors.细胞周期蛋白依赖性激酶抑制剂的结合活性预测。
J Chem Inf Model. 2015 Jul 27;55(7):1469-82. doi: 10.1021/ci500633c. Epub 2015 Jul 10.
5
Statistical analysis of EGFR structures' performance in virtual screening.表皮生长因子受体(EGFR)结构在虚拟筛选中的性能统计分析。
J Comput Aided Mol Des. 2015 Nov;29(11):1045-55. doi: 10.1007/s10822-015-9877-9. Epub 2015 Oct 17.
6
Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structures.基于多个晶体结构的虚拟筛选发现新型细胞周期检查点激酶 1 抑制剂。
J Chem Inf Model. 2011 Nov 28;51(11):2904-14. doi: 10.1021/ci200257b. Epub 2011 Oct 12.
7
Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures.基于多种蛋白质结构的分子对接与药效团搜索相结合的集成虚拟筛选策略的开发与评价。
J Chem Inf Model. 2013 Oct 28;53(10):2743-56. doi: 10.1021/ci400382r. Epub 2013 Sep 24.
8
Ensemble learning from ensemble docking: revisiting the optimum ensemble size problem.从集合对接中进行集成学习:重新探讨最优集成规模问题。
Sci Rep. 2022 Jan 10;12(1):410. doi: 10.1038/s41598-021-04448-5.
9
Use of machine learning approaches for novel drug discovery.机器学习方法在新型药物发现中的应用。
Expert Opin Drug Discov. 2016;11(3):225-39. doi: 10.1517/17460441.2016.1146250.
10
Machine Learning Assisted Approach for Finding Novel High Activity Agonists of Human Ectopic Olfactory Receptors.机器学习辅助方法寻找人类异位嗅觉受体的新型高活性激动剂。
Int J Mol Sci. 2021 Oct 26;22(21):11546. doi: 10.3390/ijms222111546.

引用本文的文献

1
Few-shot meta-learning applied to whole brain activity maps improves systems neuropharmacology and drug discovery.应用于全脑活动图谱的少样本元学习改善了系统神经药理学和药物发现。
iScience. 2024 Sep 3;27(10):110875. doi: 10.1016/j.isci.2024.110875. eCollection 2024 Oct 18.
2
Synthesis, Docking, and Machine Learning Studies of Some Novel Quinolinesulfonamides-Triazole Hybrids with Anticancer Activity.具有抗癌活性的一些新型喹啉磺胺-三唑杂合体的合成、对接和机器学习研究。
Molecules. 2024 Jul 2;29(13):3158. doi: 10.3390/molecules29133158.
3
Integrated Molecular Modeling and Machine Learning for Drug Design.

本文引用的文献

1
Inexpensive Method for Selecting Receptor Structures for Virtual Screening.用于虚拟筛选的受体结构的廉价选择方法。
J Chem Inf Model. 2016 Jan 25;56(1):21-34. doi: 10.1021/acs.jcim.5b00299. Epub 2015 Dec 29.
2
Understanding the challenges of protein flexibility in drug design.理解药物设计中蛋白质柔性的挑战。
Expert Opin Drug Discov. 2015 Dec;10(12):1301-13. doi: 10.1517/17460441.2015.1094458. Epub 2015 Sep 28.
3
Flexible receptor docking for drug discovery.用于药物发现的柔性受体对接
基于分子模拟的药物设计与机器学习的整合。
J Chem Theory Comput. 2023 Nov 14;19(21):7478-7495. doi: 10.1021/acs.jctc.3c00814. Epub 2023 Oct 26.
4
Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma.深度学习发现一种新型诱导铜死亡分子,可抑制肝癌。
Acta Pharmacol Sin. 2024 Feb;45(2):391-404. doi: 10.1038/s41401-023-01167-7. Epub 2023 Oct 6.
5
Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery.变革药物化学:人工智能在早期药物发现中的应用。
Pharmaceuticals (Basel). 2023 Sep 6;16(9):1259. doi: 10.3390/ph16091259.
6
Discrimination of psychrophilic enzymes using machine learning algorithms with amino acid composition descriptor.使用具有氨基酸组成描述符的机器学习算法鉴别嗜冷酶。
Front Microbiol. 2023 Feb 13;14:1130594. doi: 10.3389/fmicb.2023.1130594. eCollection 2023.
7
Opportunities and challenges in application of artificial intelligence in pharmacology.人工智能在药理学应用中的机遇与挑战。
Pharmacol Rep. 2023 Feb;75(1):3-18. doi: 10.1007/s43440-022-00445-1. Epub 2023 Jan 9.
8
Protein-Ligand Docking in the Machine-Learning Era.蛋白质-配体对接在机器学习时代。
Molecules. 2022 Jul 18;27(14):4568. doi: 10.3390/molecules27144568.
9
Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery.基于结构的GPCR药物发现中的基本动力学集成对接
Front Mol Biosci. 2022 Jun 29;9:879212. doi: 10.3389/fmolb.2022.879212. eCollection 2022.
10
AtomNet PoseRanker: Enriching Ligand Pose Quality for Dynamic Proteins in Virtual High-Throughput Screens.AtomNet PoseRanker:在虚拟高通量筛选中丰富动态蛋白质中配体位点的质量。
J Chem Inf Model. 2022 Mar 14;62(5):1178-1189. doi: 10.1021/acs.jcim.1c01250. Epub 2022 Mar 2.
Expert Opin Drug Discov. 2015;10(11):1189-200. doi: 10.1517/17460441.2015.1078308. Epub 2015 Aug 26.
4
Reduction of false positives in structure-based virtual screening when receptor plasticity is considered.考虑受体可塑性时基于结构的虚拟筛选中假阳性的减少。
Molecules. 2015 Mar 19;20(3):5152-64. doi: 10.3390/molecules20035152.
5
Molecular docking to flexible targets.与柔性靶点的分子对接
Methods Mol Biol. 2015;1215:445-69. doi: 10.1007/978-1-4939-1465-4_20.
6
Multi-conformer ensemble docking to difficult protein targets.针对困难蛋白质靶点的多构象集合对接
J Phys Chem B. 2015 Jan 22;119(3):1026-34. doi: 10.1021/jp506511p. Epub 2014 Sep 24.
7
Exploring the role of receptor flexibility in structure-based drug discovery.探讨受体柔性在基于结构的药物发现中的作用。
Biophys Chem. 2014 Feb;186:31-45. doi: 10.1016/j.bpc.2013.10.007. Epub 2013 Nov 9.
8
Drug design for protein kinases and phosphatases: flexible-receptor docking, binding affinity and specificity, and drug-binding kinetics.蛋白质激酶和磷酸酶的药物设计:柔性受体对接、结合亲和力和特异性以及药物结合动力学。
Curr Pharm Des. 2013;19(26):4739-54. doi: 10.2174/1381612811319260006.
9
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.有用诱饵目录增强版(DUD-E):更好的配体和诱饵,用于更好的基准测试。
J Med Chem. 2012 Jul 26;55(14):6582-94. doi: 10.1021/jm300687e. Epub 2012 Jul 5.
10
Protein flexibility in docking and surface mapping.蛋白质对接和表面作图中的构象灵活性。
Q Rev Biophys. 2012 Aug;45(3):301-43. doi: 10.1017/S0033583512000066. Epub 2012 May 9.